Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Explore key 2026 biopharma trends in AI-driven discovery, regulatory shifts, manufacturing, and FDA approvals for pharmacologists and executives.
Overcoming Drug Development Challenges: What Pharmacologists and Executives Will Gain in 2026
Explore 2026 biopharma trends including AI in drug discovery, manufacturing innovations, and regulatory strategies to overcome development challenges.
Explore 2026 pharma trends including AI in drug discovery, FDA regulatory updates, and US manufacturing investments to streamline clinical pipelines.
Explore key trends in AI-driven discovery, biopharma manufacturing, and regulatory approvals shaping drug development success in 2026.
Navigating 2026 Pharma Challenges: Key Outcomes for Drug Development and Regulatory Pros
Explore 2026 biopharma trends, AI in drug discovery, FDA approvals, and manufacturing innovations for pharmacologists and regulatory pros.
Indian drugmaker Aurobindo will need to divest four drugs from its proposed $250 million deal…
Pfizer is looking for a new CFO as Denton prepares to hang up his gloves and say goodbye to the drug company
Four years after he joined the New York drugmaker’s ranks in the wake of the…
What is Novo Nordisk’s secret weapon to turn the tide against Eli Lilly and win…
In the latest development in the Zepzelka saga, Jazz and Pharmamar’s lung cancer drug fails phase 3 trial
Early approval of Jazz Pharmaceuticals’ small cell lung cancer (SCLC) drug Zepzerka may be in…
Fierce Pharma Asia — Astellas Pharma CEO’s five-year plan. Takeda’s psoriasis victory. RA’s China Bridge Program
Astellas Pharma’s CEO briefed Fiers on the company’s new five-year plan. Takeda’s candidate wins direct…